Navigation Links
Neuroscientists find overlooked brain area is an important locus of depression
Date:2/23/2011

Cold Spring Harbor, NY -- A team of neuroscientists at Cold Spring Harbor Laboratory (CSHL), Brookhaven National Laboratory (BNL) and UC San Diego (UCSD) has collected evidence suggesting that a previously overlooked portion of the brain could be a prime locus of human depression.

In two rat models of human depression, the scientists have demonstrated that neurons in a tiny area in the central brain called the lateral habenula (LHb) are hyperactive.

Specifically, as the team reports today online ahead of print in the journal Nature, excitatory synaptic inputs onto neurons in the LHb are enhanced in "depressed" animals, a finding they regard significant because this excitation in turn causes the inhibition of "downstream targets" -- including neurons in a part of the brain called the ventral tegmental area (VTA), important in the brain's reward system and heavily populated by dopamine neurons.

Furthermore, the team, which includes Professor Fritz Henn of CSHL and BNL and Assistant Professor Bo Li of CSHL, as well as Professor Roberto Malinow of UCSD, was able to use an analog of deep brain stimulation (DBS), a novel form of electrical stimulation involving the implantation of electrodes into a specific brain area, to reverse depression-like symptoms in the rats.

DBS is an important new experimental modality of treatment for refractory depression in people, as well as a potentially important approach to treat other neurophysiological disorders, most notably Parkinson's disease. The team's results point to the LHb as a potential therapeutic target for DBS. A series of ongoing experiments in depression at other laboratories, which have shown promise in a small number of human patients, have used DBS to target an area of the cingulate cortex called Brodman's Area 25. Henn and colleagues in Germany last year reported success in treating one case of intractable human depression with DBS, targeting the LHb.

The animal models used in the team's rat experiments displayed a behavior called learned helplessness. The rats were stressed in ways that were unpredictable and inescapable; over time, they developed depression-like symptoms, notably a lack of motivation to evade unpleasant stress. "It's not a perfect model of human depression by any means," says Li, "but it is very valuable, for it does enable us to study the neural mechanisms of certain aspects of depression in people."

The team's most important decision was to study the lateral habenula. "This is an area of the brain that has often been overlooked, perhaps because of its size." Li noted, "It covers an area only about 1-2 mm across." So far only two brain imaging studies have implicated the LHb in depression because of the difficulty in resolving it using existing technologies such as PET and fMRI..

Dr. Henn, a pioneer in using learned helplessness to study depression, persuaded the team to focus on the LHb, a structure whose potential role in depression intrigued him because the LHb has elevated metabolic activity in the congenital learned helplessness model developed in his lab. The team hypothesizes that the therapeutic effect of DBS on hyperactivity in the LHb is due to the silencing effect of the high-frequency electrical pulses delivered by the implanted electrodes.

Further study of this and more broadly the mechanism behind LHb-related dysfunction is the team's most immediate priority. The rodent medial prefrontal cortex, the counterpart of Brodman's Area 25 in humans, which has already been demonstrated to be implicated in at least a subset of human depression, is one of several brain areas that send axonal projections to the habenula, Li notes. "In theory, it could be the source of the 'driving force' that makes neurons in the LHb overexcited."

"Our next important goal is to define the source of the overactivity, which appears to be due to increased glutamatergic activity," Henn states. Another priority, he says, is to better understand the mechanism of DBS in the habenula. "By applying DBS in the habenula, you're affecting the entire structure, and its entire population of neurons. We want to know which elements are critical in mediating the behavioral effect -- the relief of "depressed" symptoms -- that we have observed," Henn says.

The habenula projects not only to the VTA, but to other areas such as the Raphe nuclei, which produce serotonin, another neurotransmitter implicated in depression and which may control noradrenaline output in the brain as well. The team wants to know how the lateral habenula coordinates the activity of all three -- dopamine, serotonin and noradrenaline -- to fully understand the LHb's role in depression. Li says he intends to use highly specific methods including optogenetics to dissect different pathways of interest in the model.


'/>"/>

Contact: Peter Tarr
tarr@cshl.edu
516-367-8455
Cold Spring Harbor Laboratory
Source:Eurekalert

Related medicine news :

1. Neuroscientists reveal new links that regulate brain electrical activity
2. Ion channel responsible for pain identified by UB neuroscientists
3. MIT neuroscientists explain Proustian effect of small details attached to big memories
4. Chlamydia Often Overlooked in Young Men
5. Depression overlooked in patients with hepatitis C; compromising HCV therapy
6. Some kids with spinal cord injury may be overlooked for walking rehabilitation
7. Damage of False-Positive Mammograms Overlooked: Study
8. Gadgets not related to teenagers brain pain
9. Dementia Rates Escalate as Brain Capacity Diminishes with Age
10. Researchers discover new way to kill pediatric brain tumors
11. Scientists Pinpoint Area of Brain That Fears Losing Money
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... The StayWell Company ... NCQA. The accreditation covers StayWell’s asthma, coronary artery disease, congestive heart failure, chronic ... organizations that have excellent programs for the delivery and improvement of disease management ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... families and businesses of the greater Fort Collins area, has unveiled a collaboration ... ongoing community involvement program. Donations to this worthy cause may now be made ...
(Date:3/23/2017)... ... , ... ?This conference will prominently feature 150+ Hospital and Health System Executive Speakers including: , ... , 43rd President of the United States of America: George W. Bush , ... Out of the Ring: Sugar Ray Leonard , JD, Chairperson, McGuireWoods LLP: Amber ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... improve all aspects of people’s health and nutrition, announced its product Leyzene is ... , Natural Subsistence develops nutritional supplements that help people improve all aspects of ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... The American ... 2017 marks the 40th Anniversary of ABQAURP’s dedication to Health Care Quality and Management ... who have contributed not only to the association, but also to the Health Care ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... On Wednesday, March 22, ... at 5,821.64, up 0.48%; the Dow Jones Industrial ... and the S&P 500 closed at 2,348.45, slightly ... out of nine sectors ended the day in ... on the following Medical Instruments & Supplies equities: ...
(Date:3/23/2017)... 2017 Piramal Pharma ... gibt die Ernennung von Stuart E. Needleman ... globalen Pharmazeutikkunden eine einmalige integrierte End-to-End-Serviceplattform an ... für das erfolgreiche Wachstum und die Umsetzung ... Herr Needleman dafür verantwortlich sein, alle globalen ...
(Date:3/23/2017)... 23, 2017 Merrimack Pharmaceuticals, Inc. (NASDAQ: ... patient in a Phase 1 study of MM-310 in ... encapsulates a novel taxane and targets the EphA2 receptor, ... of many major tumor types, including prostate, ovarian, bladder, ... of this study is an important step in evaluating ...
Breaking Medicine Technology: